Feature

Booster shot back-and-forth creates uncertainty, confusion


 

Despite confusion, demand is up

Even amid all the uncertainty, there appears to be a jump in enthusiasm for the booster shots.

“The requests have gone up quite a bit. We’ve seen a number of requests from people in person and over the phone looking to get a booster,” Mr. Caswell said. “Since the discussion at the federal level...there has been a lot of interest in the third shot booster, itself, as well as about a booster for J&J.”

“There is quite a bit of excitement out there,” he said.

Dr. Edje agreed: “I take care of a fair number of folks...including the elderly and healthcare professionals. They are already asking for the booster.”

Interestingly, Dr. Edje would like to get a booster herself but is not eligible for the Pfizer third shot. She is a participant in a Moderna vaccine trial and can only receive additional immunization as part of the study.

‘Walk, don’t run’

To quell any potential early rush to get a third shot, U.S. health officials are reminding booster-ineligible people that they still have some protection against COVID-19.

“If you’re a person who ultimately might get a booster that will make you optimally protected, you don’t necessarily need to get it tomorrow,” Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases told CNN.

CDC Director Rochelle Walensky, MD, also weighed in. She told ABC that boosters for people who received a Moderna or Johnson & Johnson vaccine will be addressed with urgency.

“I want to reiterate that this is a very slow wane. There is no urgency here to go and get your booster immediately. You know, walk don’t run to your booster appointment,” she said.

“We will come and look at the data for Moderna and J&J in very short order.”

Dr. Edje and Mr. Caswell have reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Virtual Visitation: Exploring the Impact on Patients and Families During COVID-19 and Beyond
Journal of Clinical Outcomes Management
Top questions answered about COVID-19 boosters for your patients
Journal of Clinical Outcomes Management
These schools use weekly testing to keep kids in class – and COVID out
Journal of Clinical Outcomes Management
Polyethylene glycol linked to rare allergic reactions seen with mRNA COVID-19 vaccines
Journal of Clinical Outcomes Management
Children and COVID: New cases topped 200,000 after 3 weeks of declines
Journal of Clinical Outcomes Management
COVID-19 hospitalization 80% more likely for smokers
Journal of Clinical Outcomes Management
Age, C-reactive protein predict COVID-19 death in diabetes
Journal of Clinical Outcomes Management
COVID vaccination rates among pregnant people remain low
Journal of Clinical Outcomes Management
COVID-19: Greater mortality among psych patients remains a mystery
Journal of Clinical Outcomes Management
Worsening motor function tied to post COVID syndrome in Parkinson’s disease
Journal of Clinical Outcomes Management